Drug Topics
FEBRUARY 28, 2024
In order to provide the best care, it’s crucial that pharmacists stay up-to-date on the latest guidance and data for flu, COVID-19, and RSV—even when that information is constantly changing.
Pharmacy Times
FEBRUARY 28, 2024
By understanding the nuances of PBM audit strategies, pharmacies can implement proactive measures to mitigate risks of recoupment, payment suspensions, and, in severe cases, network termination.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
FEBRUARY 28, 2024
Analysis of participants who never used tobacco cigarettes showed that daily cannabis use was associated a higher risk of both heart attack and stroke.
Pharmacy Times
FEBRUARY 28, 2024
In LePage v. Center for Reproductive Medicine, the Alabama Supreme Court ruled that “extrauterine embryos” are considered children, causing some infertility clinics to halt IVF processes.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
FEBRUARY 28, 2024
An expert panel advising the Centers for Disease Control and Prevention on vaccines on Wednesday recommended that people 65 and older should get an additional Covid-19 vaccine shot this spring. The recommendation was approved by CDC Director Mandy Cohen, allowing the United States to join Canada and the United Kingdom in offering a spring booster this year to people at high risk of severe disease if they contract Covid.
Fierce Healthcare
FEBRUARY 28, 2024
LOS ANGELES — AI took center stage at the ViVE 2024 conference this week and health systems across the country are deploying the tech to tackle issues from easing the drudgery of medical docum | AI took center stage at the ViVE 2024 conference this week and health systems across the country are deploying the tech to tackle issues from easing the drudgery of medical documentation to making it easier for patients to get information about their medical care.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
FEBRUARY 28, 2024
The podcast highlights addressing misinformation, the impact of celebrity endorsements in pharmaceuticals, and the important role of pharmacists in educating patients.
STAT
FEBRUARY 28, 2024
In a bid to combat prescription drug costs, the White House will hold a listening session on Monday in search of ways to reform pharmacy benefit managers , according to people familiar with the plans. The list of attendees includes representatives from the federal government and industry, who are expected to provide insights into how the largest pharmacy benefit managers determine which medicines are covered by insurers and employers, as well as prices that are paid at pharmacy counters.
Fierce Healthcare
FEBRUARY 28, 2024
Providers, researchers and government officials gathered Tuesday to discuss the "urgent public health crisis" of gun violence and throw their weight behind a new multimillion-dollar aware | The event, which emphasized the role of healthcare professionals in addressing gun violence, came with the announcement of an industry-backed, multimillion-dollar awareness and prevention campaign.
STAT
FEBRUARY 28, 2024
In 2023, enrollment in Medicare Advantage, the version of Medicare run by private insurers, surpassed 50% of eligible beneficiaries for the very first time. Going by this headline, or perhaps the predictable flood of advertisements for plans during the fall’s open enrollment period, you might be fooled into thinking 2023 was MA’s best year yet.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
FEBRUARY 28, 2024
Danbury, Connecticut-based Nuvance Health is joining Northwell Health, New York’s largest provider and private employer, under a strategic merger agreement unveiled Wednesday. | The $18 billion combination, which still requires regulatory signoffs, would give Northwell a foothold in Connecticut and promises "significant investments" for Nuvance.
STAT
FEBRUARY 28, 2024
LONDON — Facing a growing outbreak of measles, the U.K. has unveiled an advertising campaign aimed at boosting vaccination rates in children, which have steadily fallen over the past decade and took an even greater dip during the height of the Covid-19 pandemic. The campaign, starting March 4, features children talking about their lack of protection from infections like measles and whooping cough if they’re not vaccinated.
Fierce Pharma
FEBRUARY 28, 2024
After a busy 2023 marked by multiple drug approvals, UCB isn’t resting on its laurels. | After an initial FDA approval came later than anticipated, UCB is looking to quickly grow Bimzelx. The company is eying four new indications and potential peak sales of 4 billion euros.
STAT
FEBRUARY 28, 2024
Elisabeth Bik, a microbiologist by training, has become one of the world’s most influential science detectives. An authority on scientific image analysis who’s been profiled in The New Yorker for her unique ability to spot duplicated or doctored photographs, she appeared frequently in the news over the past year as one of the experts who raised research misconduct concerns that led to an investigation into, and the eventual departure of, former Stanford president Marc Tessier-Lavig
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
FEBRUARY 28, 2024
This week on “Podnosis,” we explore the critical issue of maternal mental health. | This week on "Podnosis," Editor-in-Chief Ayla Ellison explores the critical issue of maternal mental health in an interview with Dr. Ken Levey, co-founder and CEO of Mother Goose Health.
STAT
FEBRUARY 28, 2024
One by one, the companies behind Zoloft, Prozac, and Paxil soured on psychiatry. It was the early 2000s, and as America warmed to the sounds of Sisqó and Shakira, the world’s largest pharmaceutical firms were running out of ideas to treat mental illness. Their blockbuster treatments for depression and schizophrenia had reshaped society and made billions of dollars in the process, but the old cash cows were soon to go generic.
Fierce Healthcare
FEBRUARY 28, 2024
Walgreens will now accept a slew of Medicare Advantage supplemental benefits online, including the option for home delivery, the company announced this week. | Walgreens will now accept a slew of Medicare Advantage supplemental benefits online, including the option for home delivery, the company announced this week.
STAT
FEBRUARY 28, 2024
WASHINGTON – Some twelve percent of traditional Medicare beneficiaries have heart failure. Roughly a quarter have diabetes. There’s early evidence suggesting that both conditions — and a slew of others — could be better managed with pre-made healthy meals. So why doesn’t Medicare try out delivering food to sick seniors?
Fierce Pharma
FEBRUARY 28, 2024
As Novavax emerges from its “transition year” in 2023, the vaccine maker is still raising concerns among Wall Street investors in early 2024. | As Novavax emerges from its “transition year” in 2023, the vaccine maker is still raising concerns among Wall Street investors in early 2024.
STAT
FEBRUARY 28, 2024
The 64 contestants whose discoveries and innovations have been selected for the 2024 edition of STAT Madness come from 50 institutions across the U.S. The teams include a Nobel laureate (Jennifer Doudna) and biotech big shots (Robert Langer and David Liu), but also up-and-comers. STAT Madness is our annual bracket-style competition in which readers vote on the most important and impactful biomedical and health research published in the past year by scientists at universities and independent labs
pharmaphorum
FEBRUARY 28, 2024
Discover how digital technology and strategic partnerships are revolutionising the pharmaceutical industry, enabling faster delivery of life-saving medicines to patients, while advancing humanity's fight against diseases.
STAT
FEBRUARY 28, 2024
Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far so we are determined to hang on for another couple of days. And why not? The alternatives — at least those we can identify — are not so appetizing. And what better way to make the time fly than to keep busy.
pharmaphorum
FEBRUARY 28, 2024
AbbVie has made another bolt-on deal in the immunology and inflammation category, paying $48 million upfront for rights to an antibody in preclinical development at OSE Immunotherapeutics. There’s another $665 million in potential milestones and a royalty tied to the deal, which focuses on OSE-230, billed as a potentially first-in-class activator of ChemR23, a G-protein coupled receptor (GPCR) found on some white blood cells.
Drug Store News
FEBRUARY 28, 2024
Dollar General customers can now purchase food, produce, OTCs and additional wellness products in more than 20,000 stores across the country using health supplemental benefits.
STAT
FEBRUARY 28, 2024
In a global first, some travelers and laboratory researchers who are at risk of contracting chikungunya will soon be allowed to be vaccinated against the virus. A committee of vaccine experts recommended Wednesday that those selective groups of people should be offered access to the new vaccine, Ixchiq, which is made by Valneva Austria GmbH. It will become U.S. vaccination policy when Mandy Cohen, director of the Centers for Disease Control and Prevention, signs off on the recommendation from th
Fierce Pharma
FEBRUARY 28, 2024
On the back of its $350 million deal for two late-stage Idorsia assets, Viatris will continue to be “opportunistic” when it comes to making future business development grabs—especially on the comme | On the back of its $350 million deal for two late-stage Idorsia assets, Viatris will continue to be “opportunistic” when it comes to making future business development grabs—especially on the commercial side—executives said Wednesday.
STAT
FEBRUARY 28, 2024
BETHESDA, Md. — President Joe Biden “continues to be fit for duty,” his doctor wrote Wednesday after conducting an annual physical that is being closely watched as the 81-year-old seeks reelection in November. Dr. Kevin O’Connor, Biden’s physician, wrote that the president is adjusting well to a new device that helps control his sleep apnea and has experienced some hip discomfort but also works out five times per week.
Fierce Healthcare
FEBRUARY 28, 2024
Congress is living up to its dysfunctional reputation, at least when it comes to healthcare reform. | Despite broad support, PBM reform appears unlikely in the short-term. Here's why advocates are not panicked.
Drug Topics
FEBRUARY 28, 2024
Improvement across all asthma control parameters was achieved after 12 months of biologic treatment with mepolizumab, benralizumab, and omalizumab.
Drug Store News
FEBRUARY 28, 2024
In 2023, HRG awarded 148 products predicted to have the highest potential for future success and drive profitability in independent pharmacies and other channels.
pharmaphorum
FEBRUARY 28, 2024
Peterson Health Technology Institute will review the clinical effectiveness and economic impact of digital health technologies (DHTs) for hypertension and mental health.
Pharmaceutical Technology
FEBRUARY 28, 2024
AGTC-501 is in Phase II development for retinitis in the SKYLINE trial (NCT03316560) and addresses unmet needs within the retinitis space
pharmaphorum
FEBRUARY 28, 2024
Buoyed by data from a trial of its T-cell engager (TCE) therapy in prostate cancer that almost tripled its share price, Janux Therapeutics has moved quickly to file a stock offering that could add around $200 million to its cash position. The San Diego biotech is offering $175 million in a public offering that could rise to $201.5 million if underwriters take up an option, less discounts and commissions.
Drug Topics
FEBRUARY 28, 2024
Pharmacy schools specialize in training students as experts in patient care—not as expert business owners.
Expert insights. Personalized for you.
200 
Let's personalize your content